This document describes research into new ligands for the α2-adrenergic receptor with potential anti-obesity effects. Researchers synthesized novel tetrahydroisoquinolinedione derivatives targeting the α2 receptor and tested their activity. The highest activity was found for compound A8, a 2,2-dimethyl-1,3-benzodioxole derivative. Optimization of the synthetic route found that the end product formed with the highest yield using dry 1,4-dioxane, potassium carbonate and potassium iodide at 100°C. Based on in vitro studies, compound A8 was selected for further evaluation in animal obesity models.